Hyasta Tablets 10mg, from Meiji Seika Pharma, contains Tucidinostat (YJ code: 4291074F1023, standard: 10mg 1 tablet). This orally bioavailable benzamide-type histone deacetylase (HDAC) inhibitor selectively targets HDAC isoenzymes 1, 2, 3, and 10. It is approved in Japan for relapsed or refractory adult T-cell leukemia-lymphoma, working by increasing histone acetylation and inhibiting tumor cell proliferation.
Hyasta Tablets 10mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).